Politan Capital Opens With a 6.9% Stake in AZTA

JC Parets
September 15, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Biotechnology Value Fund LP.

The hedge fund revealed a purchase of roughly $14.8 million in Olema Pharmaceuticals $OLMA.

Politan Capital Management LP filed a 13D for Azenta $AZTA, revealing an initial stake of 6.87%.

Here’s The Hot List, with data through September 14, 2023:

In another Form 4, the CEO of Prospect Capital Corporation $PSEC reported a purchase of $1,094,253.

In the options market, there was bullish flow in Teck Resources Limited $TECK, Shift4 Payments $FOUR, and American Axle & Manufacturing Holdings $AXL.

Have a great weekend. We'll be back on Monday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under